516 Survival and Surgical Outcomes in NF1 and NF2-Associated Peripheral Nerve Tumors

View at publisher Summarise with VIRAT
Authors: Barbara Buccilli, Monique Mitchell, Diogo Haddad, Amir Hossein Faraji
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: NF1 and NF2 contribute differently to peripheral nerve tumor progression. Comparative data on treatment and survival outcomes remain limited. METHODS: Using TriNetX, patients were divided into matched cohorts by NF subtype. Outcomes included excision, amputation, chemotherapy use, chronic pain, motor/sensory deficits, and survival. RESULTS: Across all tumor types, patients with NF exhibited worse survival and higher treatment burden than those without NF. In malignant peripheral nerve sheath tumors (MPNSTs), NF patients had shorter median survival (4,482 vs. 6,574 days; p = 0.033). However, survival between NF1 and NF2 subgroups was comparable (91.2% vs. 90.5%; p = 0.608). In benign peripheral nerve tumors, overall survival was paradoxically higher in NF patients (84.5%) than non-NF patients (67.7%, p < 0.001), likely reflecting earlier diagnosis and management. Surgical interventions were more common in NF-related MPNSTs, with higher excision rates (5.7% vs. 1.7%; p < 0.001) and a trend toward more amputations (2.5% vs. 1.5%; p = 0.09). NF1 and NF2 had identical excision and amputation rates (8.4%). Vision loss was more common in NF patients with MPNSTs (12.0% vs. 9.1%; p = 0.034) and benign tumors (13.5% vs. 8.0%; p < 0.001). Motor deficits were also elevated, particularly in NF1 (6.7%) compared to NF2 (0.8%; p = 0.014). Chronic pain affected more NF patients with MPNSTs (22.6% vs. 17.0%; p = 0.001), but was less frequent in benign tumors (18.3% vs. 24.5%; p < 0.001). Functional disability limiting daily activities (mRS >2) was more common in NF1 than NF2 (10.9% vs. 3.4%; p = 0.033), emphasizing the heavier neurologic burden associated with NF1. CONCLUSIONS: Neurofibromatosis is associated with increased surgical intervention, neurologic complications, and reduced survival in patients with MPNSTs. While overall outcomes were similar, NF1 was linked to greater motor deficits and functional disability, highlighting the need for subtype-specific surveillance and supportive care strategies.

Fields of Study & Subjects

Neurofibromatosis and Schwannoma Cases Meningioma and schwannoma management Glioma Diagnosis and Treatment

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
153–154
Publication date
26 March 2026
Language
EN